MoneyWorks4Me

Aurobindo Pharma informs about investor meeting

22 Feb 2023 Evaluate

Aurobindo Pharma has informed that it enclosed details of investor meeting on 23-02-2023. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This intimation is submitted pursuant to Regulation 30(6) of the Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..